Kiran Kumar, M.D.

Chief of Lymphoma and Pediatrics Radiation Oncology Services; Program Director, Medical Residency

Associate Professor

School: Medical School
Department: Radiation Oncology

You have reached the Academic Profile.

For more information on the doctor and patient care, please visit the clinical profile.

Education

Medical School: University of Chicago Pritzker School of Medicine (2013)
Internship: Presence Resurrection Medical Center (2014), Transitional Year
Residency: Stanford University Medical Center (2018), Radiation Oncology
Other Post Graduate Training: University of California - Berkeley (2018)
Graduate School: University of California - Berkeley (2018)

Publications

Primary Stereotactic Body Radiotherapy for Spinal Bone Metastases From Lung Adenocarcinoma: Chou KN, Park DJ, Hori YS, Persad AR, Chuang C, Emrish SC, Ustrzynski L, Tayag A, Kumar K, Usoz M, Mendoza M, Rahimy E, Pollom E, Soltys SG, Lai SW, Chang SD Clinical lung cancer 2024 Nov 25 e337-e347
ACR–ARS Practice Parameter for the Performance of Total Body Irradiation: Reilly M, Dandapani SV, Kumar KA, Constine L, Fogh SE, Roberts KB, Small W, Schechter NR American Journal of Clinical Oncology: Cancer Clinical Trials 2023 May 46 185-192
Serious Illness Communication Training Among Radiation Oncology Residents: Christensen M, Kumar KA, Wang WS, Dharmarajan KV, Chang Z, McStay CK, Barina A, Siropaides C Practical Radiation Oncology 2023 May 13 e220-e229
Optimizing Palliative Focal Radiation Therapy Dose in Cutaneous T-Cell Lymphoma: How Low Can You Go?: Patel AM, West L, Atluri PS, Yi SF, Rizvi S, Geethakumari PR, Awan FT, Chen W, Shah JL, Desai NB, Goff HW, Kumar KA Practical Radiation Oncology 2023 Mar 13 e192-e199
Artificial Intelligence–Empowered Radiation Oncology Residency Education: Kwon YS, Dohopolski M, Morgan H, Garant A, Sher D, Rahimi A, Sanford NN, Vo D, Albuquerque K, Kumar K, Timmerman R, Jiang SB Practical Radiation Oncology 2023 Jan 13 8-10
A Combined Biomarker of Bright CD38 and MYC ≥55% Is Highly Predictive of Double-/Triple-Hit High-Grade B-Cell Lymphoma: Alsuwaidan A, Koduru P, Fuda F, Manuel Jaso J, Chen M, Rosado F, Luu HS, Sweed N, Garcia R, Doucet M, Desai NB, Kumar KA, Awan FT, Ramakrishnan Geethakumari P, Chen W American journal of clinical pathology 2022 Sep 158 338-344
Primary central nervous system lymphoma: A real-world comparison of therapy access and outcomes by hospital setting: Patel AM, Ali O, Kainthla R, Rizvi SM, Awan FT, Patel T, Pan E, Maher E, Desai NB, Timmerman R, Kumar KA, Ramakrishnan Geethakumari P Neuro-Oncology Practice 2022 May 9 183-192
T-Cell Lymphomas, Version 2.2022: Horwitz SM, Ansell S, Ai WZ, Barnes J, Barta SK, Brammer J, Clemens MW, Dogan A, Foss F, Ghione P, Goodman AM, Guitart J, Halwani A, Haverkos BM, Hoppe RT, Jacobsen E, Jagadeesh D, Jones A, Kallam A, Kim YH, Kumar K, Mehta-Shah N, Olsen EA, Rajguru SA, Rozati S, Said J, Shaver A, Shea L, Shinohara MM, Sokol L, Torres-Cabala C, Wilcox R, Wu P, Zain J, Dwyer M, Sundar H JNCCN Journal of the National Comprehensive Cancer Network 2022 Mar 20 285-308
Volumetric Modulated Arc Therapy Enabled Total Body Irradiation (VMAT-TBI): Six-year Clinical Experience and Treatment Outcomes: Zhang-Velten ER, Parsons D, Lee P, Chambers E, Abdulrahman R, Desai NB, Dan T, Wardak Z, Timmerman R, Vusirikala M, Patel PA, Simms-Waldrip T, Aquino V, Koh A, Tan J, Iqbal Z, Zhang Y, Reynolds Jr. RR, Chiu T, Joo M, Hrycushko B, Ouyang L, Lamphier R, Yan Y, Jiang SB, Kumar KA, Gu X Transplantation and Cellular Therapy 2022 Feb 28 113.e1-113.e8
Fundamentals of radiation oncology for treatment of vertebral metastases: Gottumukkala S, Srivastava U, Brocklehurst S, Mendel JT, Kumar K, Yu FF, Agarwal A, Shah BR, Vira S, Raj KM Radiographics 2021 Nov 41 2136-2156